Uric acid: A novel treatment strategy for multiple sclerosis [2] (multiple letters)

Trends in Pharmacological Sciences

Volumn 24, Issue 11, 2003, Pages 563-564

  Mousavizadeh, Kazem ^a   Dehpour, Ahmad Reza ^b   Minagar, Alireza ^c   Ghafourifar, Pedram ^d   Neuhaus, Oliver ^e   Kieseier, Bernd C ^e   Archelos, Juan J ^f   Hartung, Hans Peter ^e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Louisiana State University School of Medicine Shreveport   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLATIRAMER; INOSINE; METHYLPREDNISOLONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; URIC ACID;

ASTROCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; GOUT; HUMAN; IMMUNOPATHOGENESIS; LETTER; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

EID: 0242352562     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.09.004     Document Type: Letter

References (13)

1. O Neuhaus Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection Trends Pharmacol. Sci. 24 2003 131 138
2. O Bagasra Activation of the inducible form of nitric oxide synthase in the brains of the patients with multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 92 1995 12041 12045
3. A.H Cross Peroxynitrite formation within the central nervous system in active multiple sclerosis J. Neuroimmunol. 88 1998 45 56
4. J.S Liu Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions Am. J. Pathol. 158 2001 2057 2066
5. P Ghafourifar Mitochondrial nitric oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation J. Biol. Chem. 274 1999 31185 31188
6. D.C Hooper Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 95 1998 675 680
7. S Spitsin Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease Mult. Scler. 7 2001 313 319
8. S Spitsin Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins Mult. Scler. 7 2001 165 166
9. S Sotgiu Serum uric acid and multiple sclerosis Neurol. Sci. 23 2002 183 188
10. D.C Hooper Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis FASEB J. 14 2000 691 698
11. G Toncev High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels Clin. Chem. Lab. Med. 40 2002 505 508
12. C.S Constantinescu Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis Mult. Scler. 6 2000 378 381
13. M.A Hediger Gateway to a long life? Nature 417 2002 393 395